-
2023-510516-39-00
Acute B-cell Lymphoblastic Leukemia with minimal residu 2019-10-30
-
2024-513372-18-00
Pre- and post-menopausal women with HR+/HER2- LABC or M 2019-10-18
-
2024-510768-21-00
Rectal cancer 2019-10-16
-
2022-502499-22-00
Beta (β) Thalassemia 2019-10-15
-
2024-517119-59-00
Rectal cancer 2019-09-26
-
2023-509821-29-00
bladder carcinoma of urothelial and non-urothelial hist 2019-09-25
-
2024-513934-40-00
Metastatic breast cancer 2019-09-20
-
2024-515080-54-00
Breast cancer 2019-08-15
-
2024-518901-16-00
RIS (Radiologically Isolated Syndrome) 2019-07-29
-
2024-511862-35-00
Adults with non-contrast-enhancing diffuse brainstem gl 2019-07-19
-
2024-518987-11-00
ADCC 2019-06-12
-
2024-517798-25-00
Aneurysmal Subarachnoid Hemorrhage (aSAH) 2019-05-17
-
2023-508302-24-00
Locally Advanced/Metastatic Urothelial Cancer 2019-05-07
-
2024-519516-14-01
Metastatic prostate cancer, Prostate cancer 2019-04-15
-
2023-509265-21-00
In-transit metastasis of malignant melanoma 2019-04-08
-
2024-512002-26-00
Muscle-invasive bladder cancer 2019-02-19
-
2024-518568-11-00
Hematological malignancies confirmed histologically:
- 2019-02-04
-
2024-512629-97-00
Patients with locally advanced or metastatic low grade 2019-01-23
-
2024-514834-19-00
Type 2 Diabetes Mellitus 2018-12-05
-
2024-515686-34-00
BRCA-related metastatic breast cancer 2018-11-16
-
2024-514780-26-00
Patients ≤50 years old with high-risk osteosarcoma (def 2018-10-23
-
2023-504631-40-01
Disorder of Consciousness, severe brain injury 2018-09-05
-
2024-512701-11-00
Systemic Juvenile Idiopathic Arthritis (sJIA) 2018-08-29
-
2024-516585-11-00
Advanced melanoma 2018-06-12